NS

NIF SMBC Ventures

North America, California, United States, Palo Alto

Description

NIF SMBC Ventures USA, Inc. is out of business. It is a venture capital firm specializing in investments at any stage of company

Investor Profile

NIF SMBC Ventures has made 11 investments, with 0 in the past 12 months and 9% as lead.

Stage Focus

  • Series B (45%)
  • Series D (9%)
  • Seed (9%)
  • Series F (9%)
  • Series Unknown (9%)
  • Series C (9%)
  • Series A (9%)

Country Focus

  • France (45%)
  • Japan (36%)
  • Australia (9%)
  • United States (9%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Medical
  • Health Diagnostics
  • Health Care
  • Pharmaceutical
  • Advertising
  • Mobile
  • Tv
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NIF SMBC Ventures frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 2
Japan Asia Investment
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
CSK Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Oak Investment Partners
North America, Connecticut, United States, Wilton
Co-Investments: 1
EDF Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Gobi Partners
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 1
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

What are some of recent deals done by NIF SMBC Ventures?

Gene Techno Science

Tokyo, Tokyo, Japan

Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.

BiopharmaBiotechnologyMedicalNursing and Residential CarePharmaceutical
Series UnknownJun 11, 2008
Amount Raised: $4,675,102
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
Series BMay 6, 2008
Amount Raised: $8,000,000
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
Series BFeb 1, 2008
Amount Raised: $6,000,000
Diatos

Paris, Ile-de-France, France

Diatos is a biopharmaceutical company developing innovative therapies for unmet medical needs in cancer.

BiotechnologyMedicalTherapeutics
Series DJul 3, 2007
Amount Raised: $12,800,000
Novexel

Romainville, Ile-de-France, France

Novexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterial

BiotechnologyHealth CareMedical
Series BJan 25, 2007
Amount Raised: $65,000,000
Digital Media Group

Sydney, New South Wales, Australia

Digital Media Group Company Ltd., a Shanghai, China-based operator of digital media networks inside subway systems.

AdvertisingMobileTV
Series BJan 8, 2007
Abionyx Pharma

Balma, Midi-Pyrenees, France

ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

BiotechnologyHealth Care
Series BNov 12, 2006
Amount Raised: $53,500,000
REGiMMUNE

Tokyo, Tokyo, Japan

REGiMMUNE is a biotechnology company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.

BiopharmaBiotechnologyHealth Diagnostics
SeedAug 15, 2006
Amount Raised: $1,600,000
Abionyx Pharma

Balma, Midi-Pyrenees, France

ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

BiotechnologyHealth Care
Series AAug 22, 2005
Amount Raised: $30,500,000
eSilicon

Sunnyvale, California, United States

eSilicon is a semiconductor design and manufacturing services company that delivers custom ICs and IPs to OEMs.

ComputerManufacturingSemiconductor
Series FFeb 14, 2005
Amount Raised: $15,000,000